Neogen Chemicals Ltd
Neogen Chemicals Ltd (NEOGEN) last reported results for the quarter ended Jun 2026, with sales of ₹250 crore and net profit of ₹17 crore. The stock last traded at ₹2,405, a market capitalisation of ₹7,225 crore, on a P/E of 203. Over the past 52 weeks the stock has ranged between ₹967 and ₹2,500. Figures are as of 6 Oct 2026 and are not real time.
Neogen Chemicals Ltd share price and key metrics
- Current price
- ₹2,405
- Market cap
- ₹7,225 cr
- Stock P/E
- 203
- Book value
- ₹309
- ROE
- 3.58%
- ROCE
- 6.46%
- Dividend yield
- 0.04%
- 52w high / low
- 2500/967
Metrics as of 6 Oct 2026. Not real time.
Track Neogen Chemicals Ltd
Cruxal reads every Neogen Chemicals Ltd filing as it lands, scores what it means for the stock, and emails you the ones that matter. Free to start.
Neogen Chemicals Ltd growth and returns
- 10 Years
- 24%
- 5 Years
- 21%
- 3 Years
- 8%
- TTM
- 18%
- 10 Years
- 19%
- 5 Years
- -2%
- 3 Years
- -17%
- TTM
- -12%
- 10 Years
- %
- 5 Years
- 13%
- 3 Years
- 9%
- 1 Year
- 55%
- 10 Years
- 9%
- 5 Years
- 7%
- 3 Years
- 5%
- Last Year
- 4%
Neogen Chemicals Ltd quarterly results
In the quarter ended Jun 2026, sales were ₹250 cr, up 33.7% from ₹187 cr a year earlier. Net profit was ₹17 cr, up 70.0% year on year.
| ₹ crore | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 |
|---|---|---|---|---|---|---|---|---|
| Sales | 193 | 201 | 203 | 187 | 209 | 220 | 247 | 250 |
| Expenses | 159 | 167 | 166 | 155 | 179 | 188 | 203 | 202 |
| Operating profit | 35 | 35 | 36 | 32 | 30 | 32 | 44 | 48 |
| OPM % | 18% | 17% | 18% | 17% | 14% | 14% | 18% | 19% |
| Other income | 1 | 1 | -13 | 1 | 2 | 2 | 1 | 4 |
| Interest | 13 | 13 | 12 | 13 | 19 | 22 | 21 | 21 |
| Depreciation | 7 | 7 | 7 | 6 | 7 | 7 | 8 | 8 |
| Profit before tax | 15 | 15 | 4 | 14 | 5 | 6 | 16 | 23 |
| Tax % | 29% | 34% | 35% | 28% | 35% | 36% | 28% | 26% |
| Net profit | 11 | 10 | 2 | 10 | 3 | 4 | 11 | 17 |
| EPS (₹) | 4.15 | 3.79 | 0.91 | 3.89 | 1.28 | 1.40 | 4.32 | 6.25 |
Consolidated figures as reported by the company. Percentages are as published; totals may not sum exactly.
Neogen Chemicals Ltd annual results
| ₹ crore | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | TTM |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 110 | 161 | 239 | 306 | 336 | 487 | 686 | 691 | 778 | 862 | 926 |
| Operating profit | 20 | 29 | 43 | 58 | 64 | 87 | 112 | 110 | 136 | 137 | 154 |
| OPM % | 18% | 18% | 18% | 19% | 19% | 18% | 16% | 16% | 18% | 16% | 17% |
| Net profit | 8 | 11 | 21 | 29 | 31 | 45 | 50 | 36 | 35 | 29 | 36 |
| EPS (₹) | 3.84 | 5.49 | 10.43 | 12.28 | 13.43 | 17.90 | 20.04 | 13.51 | 13.20 | 10.90 | 13.25 |
TTM is the trailing twelve months to the most recent quarter.
Neogen Chemicals Ltd balance sheet
| ₹ crore | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|---|---|---|
| Equity capital | 20 | 20 | 20 | 23 | 23 | 25 | 25 | 26 | 26 | 26 |
| Reserves | 22 | 30 | 50 | 133 | 160 | 414 | 458 | 734 | 763 | 790 |
| Borrowings | 69 | 82 | 120 | 137 | 222 | 229 | 370 | 409 | 597 | 1,395 |
| Other liabilities | 41 | 48 | 56 | 61 | 87 | 131 | 202 | 292 | 361 | 691 |
| Total liabilities | 152 | 180 | 246 | 355 | 492 | 799 | 1,054 | 1,461 | 1,747 | 2,902 |
| Fixed assets | 56 | 67 | 83 | 111 | 127 | 285 | 347 | 496 | 404 | 475 |
| CWIP | 1 | 1 | 0 | 3 | 115 | 11 | 36 | 109 | 156 | 857 |
| Investments | 0 | 0 | 1 | 1 | 1 | 82 | 77 | 0 | 0 | 0 |
| Other assets | 94 | 112 | 163 | 241 | 250 | 422 | 594 | 856 | 1,187 | 1,570 |
| Total assets | 152 | 180 | 246 | 355 | 492 | 799 | 1,054 | 1,461 | 1,747 | 2,902 |
As reported by the company. Total assets equal total liabilities by construction.
Neogen Chemicals Ltd cash flow
| ₹ crore | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|---|---|---|
| Cash from operations | 0 | 12 | -4 | -35 | 84 | 1 | -30 | -29 | 196 | -231 |
| Cash from investing | -33 | -13 | -20 | -29 | -135 | -146 | -94 | -216 | -317 | -410 |
| Cash from financing | 33 | -0 | 24 | 63 | 51 | 188 | 100 | 237 | 113 | 642 |
| Net cash flow | 1 | -1 | 0 | -1 | -0 | 44 | -25 | -8 | -8 | -0 |
| Free cash flow | -33 | -1 | -24 | -63 | -51 | -65 | -134 | -332 | -121 | -647 |
| CFO / operating profit | 21% | 55% | 4% | -38% | 146% | 13% | -17% | -18% | 153% | -154% |
Negative figures are outflows. CFO / operating profit is a ratio, not an amount.
Neogen Chemicals Ltd operating ratios
| Per year | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|---|---|---|
| ROCE % | 23% | 23% | 26% | 22% | 17% | 14% | 13% | 9% | 9% | 6% |
| Debtor days | 107 | 94 | 93 | 90 | 85 | 82 | 94 | 149 | 94 | 161 |
| Inventory days | 228 | 192 | 188 | 257 | 211 | 258 | 275 | 365 | 267 | 445 |
| Days payable | 177 | 141 | 111 | 71 | 122 | 131 | 147 | 138 | 227 | 346 |
| Cash conversion cycle | 158 | 145 | 169 | 276 | 174 | 209 | 223 | 376 | 134 | 260 |
| Working capital days | 174 | 48 | 63 | 95 | 66 | 111 | 79 | 129 | 123 | 85 |
Ratios as computed by the source from the reported statements. Rows a company does not report are omitted.
Neogen Chemicals Ltd shareholding pattern
Promoters held 48.31% at Sep 2026, down from 51.22% at Sep 2025. FIIs 4.51% and DIIs 23.43%.
| % held | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 | Sep 2026 |
|---|---|---|---|---|---|---|---|---|
| Promoters | 51.22% | 51.22% | 51.22% | 51.22% | 51.22% | 51.22% | 53.00% | 48.31% |
| FIIs | 7.73% | 7.79% | 7.35% | 5.15% | 4.57% | 4.46% | 4.11% | 4.51% |
| DIIs | 22.52% | 22.75% | 22.96% | 25.22% | 21.99% | 22.65% | 19.60% | 23.43% |
| Public | 18.51% | 18.22% | 18.45% | 18.40% | 22.21% | 21.67% | 23.27% | 23.75% |
| No. of shareholders | 47,651 | 46,104 | 46,321 | 45,710 | 47,884 | 54,332 | 61,988 | 68,410 |
As disclosed by the company to the exchanges. The last row is a count of shareholders, not a percentage.
Cruxal coverage of Neogen Chemicals Ltd
Neogen Chemicals Ltd corporate filings
- Neogen Chemicals' subsidiary NML secures INR 76.80 crore capital infusion from JV partner Morita Investment LimitedCompany Updatehigh impact
Cruxal's analysis: Neogen Chemicals Limited has announced that its step-down subsidiary, Neogen Morita New…
Read the full analysis - Neogen Chemicals Credit Outlook Upgraded to Stable by CRISIL Following Successful 600 Crore QIPCompany Updatehigh impact
Cruxal's analysis: Neogen Chemicals Limited has received a positive credit rating action from CRISIL, with…
Read the full analysis - Intimation of closure of trading windowInsider Trading / SASTlow impact
- Neogen Chemicals Ltd schedules analyst/investor meeting for September 28, 2026Company Updatelow impact
Cruxal's analysis: Neogen Chemicals has announced an analyst and investor meeting scheduled for September…
Read the full analysis - Neogen Chemicals successfully raises INR 600 crore via oversubscribed QIP to deleverage balance sheetCompany Updatehigh impact
Cruxal's analysis: Neogen Chemicals Limited has successfully completed its first-ever Qualified Institutions…
Read the full analysis - Neogen Chemicals Ltd schedules analyst and investor meeting for September 22, 2026Company Updatelow impact
Cruxal's analysis: Neogen Chemicals has announced an analyst and investor meeting scheduled for September…
Read the full analysis - Neogen Chemicals successfully concludes QIP, raising 600 crore at 2,255 per shareCompany Updatehigh impact
Cruxal's analysis: Neogen Chemicals Limited has successfully completed its Qualified Institutions Placement…
Read the full analysis - Neogen Chemicals Limited Successfully Closes QIP, Raising Approximately 600 Crore INRCompany Updatehigh impact
Cruxal's analysis: Neogen Chemicals Limited has successfully concluded its Qualified Institutions Placement…
Read the full analysis - Neogen Chemicals Limited Initiates Qualified Institutions Placement (QIP) with Floor Price of INR 2,189.73 per ShareCompany Updatehigh impact
Cruxal's analysis: Neogen Chemicals Limited has officially opened its Qualified Institutions Placement (QIP)…
Read the full analysis - Neogen Chemicals receives Show Cause cum Demand Notice from CGST CommissionerCompany Updatelow impact
Cruxal's analysis: Neogen Chemicals has disclosed the receipt of a Show Cause cum Demand Notice from the…
Read the full analysis - Neogen Chemicals approves Business Transfer Agreement between NIL and NMLCompany Updatelow impact
Cruxal's analysis: Neogen Chemicals Ltd (NIL) has approved the execution of a Business Transfer Agreement…
Read the full analysis - Neogen Chemicals Ltd: Disclosure of insider trading activity under SEBI Regulation 7(2)Company Updatelow impact
Cruxal's analysis: Neogen Chemicals has filed a disclosure pursuant to Regulation 7(2) of the SEBI…
Read the full analysis - Neogen Chemicals Limited concludes 37th AGM; shareholders approve final dividend of INR 1 per share and authorize future fundraisingAGM/EGMmedium impact
Cruxal's analysis: Neogen Chemicals Limited has successfully concluded its 37th Annual General Meeting…
Read the full analysis - Neogen Chemicals Concludes 37th AGM; Seeks Shareholder Approval for Fund-Raising and Declares DividendAGM/EGMmedium impact
Cruxal's analysis: Neogen Chemicals Limited has concluded its 37th Annual General Meeting, where…
Read the full analysis - SBI Mutual Fund reduces stake in Neogen Chemicals Limited by 0.77%Insider Trading / SASTmedium impact
Cruxal's analysis: Neogen Chemicals Limited has disclosed that SBI Mutual Fund has sold 2 lakh 11 thousand…
Read the full analysis - SBI Mutual Fund reduces stake in Neogen Chemicals Limited by 0.7740% via open market saleInsider Trading / SASTlow impact
Cruxal's analysis: Neogen Chemicals Limited has witnessed a reduction in shareholding by institutional…
Read the full analysis
This page shows filings on a one-hour delay. Sign in to see them as they land, with Cruxal's analysis of what each one means.
Cruxal publishes market data and coverage for information only. Nothing here is investment advice.